Efficacy of intravitreal bevacizumab with panretinal photocoagulation followed by ahmed valve implantation in neovascular glaucoma

Journal of Glaucoma

Volumn 22, Issue 9, 2013, Pages 768-772

  Mahdy, Reda A ^a   Nada, Waled M ^a   Fawzy, Khaled M ^a   Alnashar, Haitham Y ^a   Almosalamy, Salah M ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

Ahmed valve implantation; bevacizumab; intravitreal; neovascular glaucoma; panretinal photocoagulation

Indexed keywords

BEVACIZUMAB; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGED; AHMED VALVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; LASER COAGULATION; MALE; NEOVASCULAR GLAUCOMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VISUAL ACUITY; ANTAGONISTS AND INHIBITORS; COMPARATIVE STUDY; GLAUCOMA DRAINAGE IMPLANT; GLAUCOMA, NEOVASCULAR; INTRAOCULAR PRESSURE; INTRAVITREAL DRUG ADMINISTRATION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OCULOPLETHYSMOGRAPHY; PHYSIOLOGY; PROSPECTIVE STUDY; PROSTHESIS IMPLANTATION; TRABECULAR MESHWORK; TREATMENT OUTCOME;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FEMALE; GLAUCOMA DRAINAGE IMPLANTS; GLAUCOMA, NEOVASCULAR; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; LASER COAGULATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESIS IMPLANTATION; TONOMETRY, OCULAR; TRABECULAR MESHWORK; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84890562230     PISSN: 10570829     EISSN: 1536481X     Source Type: Journal    
DOI: 10.1097/IJG.0b013e318259aec4     Document Type: Article

References (32)

1. Stamper RL, Lieberman MF, Drake MV. Angle-Closure Glaucoma Without Papillary Block. Becker Shaffer's Diagnosis and Therapy of the Glaucomas. 7th ed. St Louis: Mosby Inc.; 1999: 251-257
2. Hayreh SS. Neovascular glaucoma. Prog Retin Eye Res. 2007; 26: 470-485
3. Ng EW, Adamis AP. Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration. Can J Ophthalmol. 2005;40: 352-368
4. Gaudreault J, Fei D, Rusit J, et al. Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration. Invest Ophthalmol Vis Sci. 2005;46: 726-733
5. Avery RL, Pieramici DJ, Rabena MD, et al. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology. 2006;113: 363-365
6. Krzystolik MG, Afshari MA, Adamis AP, et al. Prevention of experimental choroidal neovascularization with intravitreal antivascular endothelial growth factor antibody fragment. Arch Ophthalmol. 2002;120: 338-346
7. Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab Avastin) for neovascular age-related macular degeneration). Ophthalmic Surg Lasers Imaging. 2005;36: 331-335
8. Arevalo JF, Wu L, Sanchez JG, et al. Intravitreal bevacizumab (Avastin) for proliferative diabetic retinopathy: 6-months followup. Eye. 2007;23: 117-123
9. Ishikawa K, Honda S, Tsukahara Y, et al. Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy. Eye. 2007;23: 108-111
10. Lynch SS, Cheng CM. Bevacizumab for neovascular ocular diseases. Ann Pharmacother. 2007;41: 614-625
11. Costa RA, Jorge R, Calucci D, et al. Intravitreal bevacizumab (Avastin) for central and hemicentral retinal vein occlusions: IBeVO study. Retina. 2007;27: 141-149
12. Avery RL, Pearlman J, Pieramici DJ, et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology. 2006;113: 1695-1705
13. Jaissle GB, Ziemssen F, Petermeier K, et al. Bevacizumab for treatment of macular edema secondary to retinal vein occlusion. Ophthalmologe. 2006;103: 471-475
14. Bock F, Konig Y, Dietrich T, et al. Inhibition of angiogenesis in the anterior chamber of the eye. Ophthalmologe. 2007;104: 336-344
15. Kiss C, Michels S, Prager F, et al. Evaluation of anterior chamber inflammatory activity in eyes treated with intravitreal bevacizumab. Retina. 2006;26: 877-881
16. Gheith ME, Siam GA, De Barros DS, et al. Role of intravitreal bevacizumab in neovascular glaucoma. J Ocul Pharmacol Ther. 2007;23: 487-491
17. Chilov MN, Grigg JR, Playfair TJ. Bevacizumab (Avastin) for the treatment of neovascular glaucoma. Clin Exp Ophthalmol. 2007;35: 494-496
18. Da Mata A, Burk SE, Netland PA, et al. Management of uveitis glaucoma with Ahmed glaucoma valve implantation. Ophthalmology. 1999;106: 2168-2172
19. Morad Y, Donaldson CE, Kim YM, et al. The Ahmed drainage implant in the treatment of pediatric glaucoma. Am J Ophthalmol. 2003;135: 821-829
20. Topouzis F, Coleman A, Alchoplin N. Follow up of the original cohort with the Ahmed glaucoma valve implant. Am J Ophthalmol. 1999;127: 27-33
21. Huang MC, Netland PA, Coleman AL. Intermediate term clinical experience with Ahmed Glaucoma valve implant. Am J Ophthalmol. 1999;127: 27-33
22. Lavin MJ, Franks WA, Wormald RPL. Clinical risk factors for failure in glaucoma tube surgery. Arch Ophthalmol. 1992; 110: 480-485
23. Tripathi RC, Li J, Tripathi BJ, et al. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology. 1998;105: 232-237
24. Kahook MY, Schuman JS, Noecker RJ. Intravitreal bevacizumab in a patient with neovascular glaucoma. Ophthalmic Surg Lasers Imaging. 2006;37: 144-146
25. Davidorf FH, Mouser JG, Derick RJ. Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection. Retina. 2006;26: 354-356
26. Yazdani S, Hendi K, Pakravan M. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma. J Glaucoma. 2007;16: 437-439
27. Iliev ME, Domig D, Wolf-Schnurrbursch U, et al. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol. 2006;142: 1054-1056
28. Ghanem AA, El-Kannishy AM, El-Wehidy AS, et al. Intravitreal bevacizumab (Avastin) as an adjuvant treatment in cases of neovascular glaucoma. Middle East Afr J Ophthalmol. 2009;16: 75-79
29. Eid TM, Radwan A, El-Manawy W, et al. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: Safety and efficacy. Can Ophthalmol. 2009;44: 451-456
30. Saito Y, Higashide T, Takeda H, et al. Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma. Acta Ophthalmol. 2010;88: 96-102
31. Sothornwit N. Intravitreal bevacizumab for Ahmed glaucoma valve implantation in neovascular glaucoma: A case report. J Med Assoc Thai. 2008;91(suppl 1): S162-S165
32. Yang JY, Kim JH, Kim NR, et al. Surgical results of Ahmed valve implantation with intraoperative bevacizumab injection in patients with neovascular glaucoma. J Glaucoma. 2012;21: 331-336